Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood

Arthritis and Rheumatology

Volumn 69, Issue 8, 2017, Pages 1689-1700

  Schepp, Johanna ^a   Proietti, Michele ^a   Frede, Natalie ^a   Buchta, Mary ^a   Hübscher, Katrin ^a   Rojas Restrepo, Jessica ^a   Goldacker, Sigune ^a   Warnatz, Klaus ^a   Pachlopnik Schmid, Jana ^b   Duppenthaler, Andrea ^c   Lougaris, Vassilios ^d   Uriarte, Ignacio ^e   Kelly, Susan ^f   Hershfield, Michael ^f   Grimbacher, Bodo ^a,g  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF BRESCIA   (Italy)

^e Child Mother Hospital Vitorio Tetamanti   (Argentina)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CD27 ANTIGEN; CECR1 PROTEIN; COMPLEMENTARY DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; STEROID; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; ADENOSINE DEAMINASE; CECR1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADENOSINE DEAMINASE 2 DEFICIENCY; ADENOSINE DEAMINASE DEFICIENCY; ADULTHOOD; ALOPECIA; ANEMIA; ANTIBIOTIC PROPHYLAXIS; APHTHOUS STOMATITIS; ARTHRALGIA; ARTICLE; ASTHMA; AUTISM; B LYMPHOCYTE; CANDIDA; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DEVELOPMENTAL DELAY; DISORDER OF SEX DEVELOPMENT; ECZEMA; ENTEROPATHY; ENZYME ACTIVITY; EPILEPSY; EPISCLERITIS; ERYTHEMA NODOSUM; ESCHERICHIA COLI; EXON; FEMALE; FEVER; FIBROMYALGIA; GENETIC SCREENING; HAEMOPHILUS PARAINFLUENZAE; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS; HEPATOMEGALY; HERPES SIMPLEX; HERPES ZOSTER; HERPETIC STOMATITIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERTENSION; HYPOPHYSIS ADENOMA; IMMUNE DYSREGULATION; IMMUNOGLOBULIN DEFICIENCY; INTELLECTUAL IMPAIRMENT; INTESTINE INFECTION; INTRON; KIDNEY FAILURE; LEUKOPENIA; LIVEDO RETICULARIS; LUNG ABSCESS; LYMPHADENOPATHY; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MENINGITIS; MICROSCOPIC COLITIS; MONOCYTE; MOUTH ULCER; MULTIPLE ORGAN FAILURE; MYALGIA; MYOSITIS; NEPHRITIS; NEUTROPENIA; NEXT GENERATION SEQUENCING; ONSET AGE; PARESTHESIA; PHENOTYPE; PNEUMONIA; POINT MUTATION; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS; RECURRENT INFECTION; SANGER SEQUENCING; SINUSITIS; SKIN ULCER; SPLENOMEGALY; STREPTOCOCCUS; THROMBOCYTOPENIA; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VASCULAR LESION; VIRUS ENCEPHALITIS; WESTERN BLOTTING; WILD TYPE; ADOLESCENT; ADULT; DNA SEQUENCE; GENETICS; HIGH THROUGHPUT SEQUENCING; HOMOZYGOTE; IMMUNE DEFICIENCY; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; MUTATION; VASCULAR DISEASE; YOUNG ADULT;

ADENOSINE DEAMINASE; ADOLESCENT; ADULT; B-LYMPHOCYTES; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOMOZYGOTE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; SEQUENCE ANALYSIS, DNA; STROKE; VASCULAR DISEASES; YOUNG ADULT;

EID: 85021820648     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.40147     Document Type: Article

References (22)

1. Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Stone DL, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 2014;370:911–20.
2. Navon EP, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 2014;370:921–31.
3. Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol 2010;88:279–90.
4. Kaljas Y, Liu C, Skaldin M, Wu C, Zhou Q, Lu Y, et al. Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mol Life Sci 2017;74:555–70.
5. Schepp J, Bulashevska A, Mannhardt-Laakmann W, Cao H, Yang F, Seidl M, et al. Deficiency of adenosine deaminase 2 causes antibody deficiency. J Clin Immunol 2016;36:179–86.
6. Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, et al. Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr 2016;177:316–20.
7. Van Eyck L, Liston A, Meyts I. Mutant ADA2 in vasculopathies [letter]. N Engl J Med 2014;371:478–9.
8. Van Montfrans J, Zavialov A, Zhou Q. Mutant ADA2 in vasculopathies [letter]. N Engl J Med 2014;371:478.
9. Belot A, Wassmer E, Twilt M, Lega JC, Zeef LA, Oojageer A, et al. Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J 2014;12:44.
10. Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, et al. A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations. J Rheumatol 2015;42:1532–4.
11. Van Eyck L Jr, Hershfield MS, Pombal D, Kelly SJ, Ganson NJ, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol 2015;135:283–7.e5.
12. Gonzalez Santiago TM, Zavialov A, Saarela J, Seppanen M, Reed AM, Abraham RS, et al. Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol 2015;151:1230–4.
13. Uettwiller F, Sarrabay G, Rodero MP, Rice GI, Lagrue E, Marot Y, et al. ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters. RMD Open 2016;2:e000236.
14. Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, et al. Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheumatol 2016;68:2314–22.
15. Van Montfrans JM, Hartman EA, Braun KP, Hennekam EA, Hak EA, Nederkoorn PJ, et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford) 2016;55:902–10.
16. Hsu AP, West RR, Calvo KR, Cuellar-Rodriguez J, Parta M, Kelly SJ, et al. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: successful hematopoietic stem cell transplantation. J Allergy Clin Immunol 2016;138:628–30.e2.
17. Taskinen MH, Mustjoki S, Jahnukainen K, Trotta L, Siitonen T, Hautala T, et al. Large granular lymphocyte infiltration in the bone marrow in children and young adults may suggest primary immune deficiency. Blood 2015;126:1024.
18. Sasa GS, Elghetany MT, Bergstrom K, Nicholas S, Himes R, Krance RA, et al. Adenosine deaminase 2 deficiency as a cause of pure red cell aplasia mimicking Diamond Blackfan anemia. Blood 2015;126:3615.
19. Fellmann F, Angelini F, Wassenberg J, Perreau M, Arenas RN, Simon G, et al. IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation. J Allergy Clin Immunol 2016;137:1189–96.e2.
20. Barron K, Ombrello A, Stone D, Hoffmann P, Aksentijevich I, Zhou Q, et al. Clinical follow-up on a cohort of patients with deficiency of adenosine deaminase 2 (DADA2). Pediatr Rheumatol 2015;13 Suppl 1:O21.
21. Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr 1997;130:388–93.
22. Morbach H, Eichhorn EM, Liese JG, Girschick HJ. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol 2010;162:271–9.